[(16E,18E)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] 2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)oxyacetyl]-methylamino]propanoate

• 分子结构分类: 有机化合物 - 苯类化合物 - 芴
• 英文名称: [(16E,18E)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] 2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)oxyacetyl]-methylamino]propanoate
• 化学式: C₄₉H₅₇ClN₄O₁₃
• 分子量: 945.4
• InChiKey: AHOYCZVXIBQDSZ-UYRRGKPESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  67
• 可旋转键数：
  12
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  204
• 氢给体数：
  3
• 氢受体数：
  13

文献信息

• Conjugates comprising cell-binding agents and cytotoxic agents
  申请人：ImmunoGen, Inc.

  公开号：US10988531B2

  公开（公告）日：2021-04-27

  The invention relates to novel cell-binding agent-cytotoxic agent conjugates, wherein the cell-binding agent (CBA) is covalently linked to the cytotoxic agent through an aldehyde group obtained from oxidation of a 2-hydroxyethylamine moiety on the CBA. The invention also provides methods of preparing the conjugates of the present invention. The invention further provides composition and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the conjugates of the invention.

  本发明涉及新型细胞结合剂-细胞毒剂共轭物，其中细胞结合剂（CBA）通过CBA上的2-羟乙基胺氧化得到的醛基与细胞毒剂共价连接。本发明还提供了制备本发明共轭物的方法。本发明进一步提供了使用本发明共轭物抑制哺乳动物异常细胞生长或治疗增殖性疾病的组合物和方法。
• CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS
  申请人：ImmunoGen, Inc.

  公开号：US20160095938A1

  公开（公告）日：2016-04-07

  The invention relates to novel cell-binding agent-cytotoxic agent conjugates, wherein the cell-binding agent (CBA) is covalently linked to the cytotoxic agent through an aldehyde group obtained from oxidation of a 2-hydroxyethylamine moiety on the CBA. The invention also provides methods of preparing the conjugates of the present invention. The invention further provides composition and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the conjugates of the invention.
• [EN] CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS<br/>[FR] CONJUGUÉS COMPRENANT DES AGENTS DE LIAISON CELLULAIRE (CBA) ET DES AGENTS CYTOTOXIQUES
  申请人：IMMUNOGEN INC

  公开号：WO2014134457A2

  公开（公告）日：2014-09-04

  The invention provides linker compounds and cytotoxic compounds that are useful for forming a CBA-drug conjugate and conjugates so formed. Such conjugates and/or cytotoxic compounds may be effective for treating a range of diseases, such as cancer, with a relatively high activity at a relatively low, non-toxic dose.